-
Signature
-
/s/ Avraham S. Adler, Attorney-in-Fact
-
Issuer symbol
-
PTCT
-
Transactions as of
-
06 Jan 2026
-
Net transactions value
-
-$383,016
-
Form type
-
4
-
Filing time
-
08 Jan 2026, 17:20:08 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Boulding Mark Elliott |
EXEC. VP AND CLO |
C/O PTC THERAPEUTICS, INC., 500 WARREN CORPORATE CENTER DRIVE, WARREN |
/s/ Avraham S. Adler, Attorney-in-Fact |
08 Jan 2026 |
0001578852 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
PTCT |
Common Stock |
Sale |
$133,816 |
-1,739 |
-1.4% |
$76.95 |
119,162 |
06 Jan 2026 |
Direct |
F1 |
| transaction |
PTCT |
Common Stock |
Sale |
$116,452 |
-1,503 |
-1.3% |
$77.48 |
117,659 |
07 Jan 2026 |
Direct |
F2 |
| transaction |
PTCT |
Common Stock |
Options Exercise |
$100,012 |
+2,625 |
+2.2% |
$38.10 |
120,284 |
07 Jan 2026 |
Direct |
F3 |
| transaction |
PTCT |
Common Stock |
Sale |
$126,306 |
-1,638 |
-1.4% |
$77.11 |
118,646 |
07 Jan 2026 |
Direct |
F3, F4 |
| transaction |
PTCT |
Common Stock |
Sale |
$73,937 |
-949 |
-0.8% |
$77.91 |
117,697 |
07 Jan 2026 |
Direct |
F3, F5 |
| transaction |
PTCT |
Common Stock |
Sale |
$2,987 |
-38 |
-0.03% |
$78.60 |
117,659 |
07 Jan 2026 |
Direct |
F3 |
| transaction |
PTCT |
Common Stock |
Options Exercise |
$28,613 |
+751 |
+0.64% |
$38.10 |
118,410 |
07 Jan 2026 |
Direct |
F3 |
| transaction |
PTCT |
Common Stock |
Sale |
$36,314 |
-471 |
-0.4% |
$77.10 |
117,939 |
07 Jan 2026 |
Direct |
F3, F6 |
| transaction |
PTCT |
Common Stock |
Sale |
$20,960 |
-269 |
-0.23% |
$77.92 |
117,670 |
07 Jan 2026 |
Direct |
F3, F7 |
| transaction |
PTCT |
Common Stock |
Sale |
$869 |
-11 |
-0.01% |
$78.98 |
117,659 |
07 Jan 2026 |
Direct |
F3 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
PTCT |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-2,625 |
-78% |
$0.000000 |
751 |
07 Jan 2026 |
Common Stock |
2,627 |
$38.10 |
Direct |
F3, F8 |
| transaction |
PTCT |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-751 |
-100% |
$0.000000 |
0 |
07 Jan 2026 |
Common Stock |
751 |
$38.10 |
Direct |
F3, F8 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: